Pharmacist-Provided Contraception: Easier, Better, Faster, Longer?
Pharmacist-Provided Contraception: Easier, Better, Faster, Longer?
State-based efforts to improve access to hormonal contraception through pharmacist prescribing are growing. July’s Journal Club examines published data comparing outcomes with prescription origination, making the case for pharmacist prescribing.
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
1. Recognize opportunities for, and potential benefits of, expansion of patient access to hormonal contraception through direct pharmacist prescribing
2. Recall key components of the United States Medical Eligibility Criteria for Contraceptive Use which guide prescribing of hormonal contraceptives
3. Describe the design and results of a cohort study evaluating pharmacist versus clinician prescribed hormonal contraception
4. Assess strengths and limitations of a cohort study evaluating pharmacist versus clinician prescribed hormonal contraception
5. Determine the potential outcomes of pharmacist prescribed hormonal contraception based on a cohort study
Caitlin Mardis, PharmD, BCPS
Director of Continuing Education and Professional Development
Clinical Assistant Professor, Clinical Pharmacy & Outcomes Sciences
University of South Carolina
Caitlin Mardis does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.
To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read the study listed below, complete all course materials, successfully pass the exam (CEimpact provides two (2) opportunities to complete the exam), and submit the evaluation.
Rodriguez MI, Edelman AB, Skye M, Anderson L, Darney BG. Association of pharmacist prescription with dispensed duration of hormonal contraception. JAMA Netw Open. 2020 May 1;3(5):e205252. doi: 10.1001/jamanetworkopen.2020.5252.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2766072
This course is included in our Pharmacist Membership. To get more courses like this every month, sign-up!
Fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: July 14, 2021
Planned Expiration Date: July 14, 2024
RV3-4.24/EXP
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
| Duration | 1h 0m |
|---|---|
| Topic Designator | Disease State/Drug Therapy |
| ACPE | Yes |
| ACPE Topic | 01 Drug Therapy |
| Role | Pharmacist |
| Media-Type | On-Demand |
| Release Date | 7/14/21 |
| CEUs | 0.1 |
| Rating | 4 |
| ACPE Number | 0107-0000-21-216-H01-P |
